Stocks › Drug Manufacturers - General › JNJ

Johnson & Johnson JNJ

US equityMarket cap rank #22Drug Manufacturers - General CAR-T Therapy Infectious Disease

$270.62

+$1.45 (+0.54%)

Market open · Sep 24, 1:10 pm ET

After hours $268.71 -0.17%

Open$269.50

Prev close$269.17

Day range$269.01 – $275.23

Volume2.31M

Market cap$652.05B

P/E (TTM)31.4

Dividend yield1.94%

Johnson & Johnson(JNJ.US) Officer Sells US$9.23 Million in Common Stock Market news · 4 Sep 2026
UBS Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $320 Market news · 3 Sep 2026
UBS Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $320 Market news · 2 Sep 2026
TD Cowen Initiates Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $300 Market news · 15 Sep 2026
DBS Maintains Johnson & Johnson(JNJ.US) With Hold Rating, Raises Target Price to $270 Market news · 12 Sep 2026
Apollo Global Management (APO.US) is reportedly in talks to acquire Johnson & Johnson's (JNJ.US) orthopedics business, with the potential deal valued at nearly $20 billion. Zhitong Finance · 12 Sep 2026
RBC Capital Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $287 Market news · 11 Sep 2026
Guggenheim Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $287 Market news · 6 Aug 2026
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating Market news · 5 Aug 2026
Morgan Stanley Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $294 Market news · 4 Aug 2026
Wells Fargo Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $282 Market news · 3 Aug 2026
Goldman Sachs Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $282 Market news · 26 Aug 2026
Scotiabank Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Maintains Target Price $305 Market news · 25 Aug 2026
Citi Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Announces Target Price $298 Market news · 13 Aug 2026
Argus Research Maintains Johnson & Johnson(JNJ.US) With Buy Rating, Raises Target Price to $300 Market news · 29 Jul 2026